Melanoma Clinical Trials in New York

Showing 261-280 of 311 trials

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

NCT00124124

In this study, a melanoma vaccine (5 melanoma peptides) is given with either Montanide or dendritic cells as adjuvants. This randomized trial will establish the safety of both vaccines and compare the 2 vaccine adjuvants in their efficacy to induce immune responses.

Melanoma

Dr. Nina Bhardwaj50 participantsStarted Jul 2005

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00470470

This phase II trial is studying how well imatinib mesylate works in treating patients with stage III or stage IV melanoma that cannot be removed by surgery. Imatinib mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more

National Cancer Institute (NCI)30 participantsStarted Apr 2007

Los Angeles, California, United States • Miami Beach, Florida, United States • West Palm Beach, Florida, United States +5 more locations

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Melanoma Trials in Other Cities

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Vaccine Therapy in Treating Patients With Malignant Melanoma

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

SciBase International Melanoma Pivotal Study

Other Conditions in New York